Dan S. Suesskind - 27 Jul 2026 Form 4 Insider Report for Nano-X Imaging Ltd. (NNOX)

Reporting relationship: Director
Issuer ticker: NNOX
Reported as of: 27 Jul 2026
Net transaction value: +$46,500
SEC form: 4
Accepted by SEC: 29 Jul 2026, 07:40:12 UTC
Prior SEC filing: 30 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Marina Gofman Feler, attorney-in-fact

Key filing fact

Dan S. Suesskind filed Form 4 for Nano-X Imaging Ltd. (NNOX) on 29 Jul 2026.

Key facts

This page summarizes Dan S. Suesskind's Form 4 filing for Nano-X Imaging Ltd. (NNOX).
2 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 29 Jul 2026, 07:40.

Change

Previous filing in this sequence was filed on 30 Apr 2026.
Current net transaction value: +$46,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001303873 Primary reporting owner

Suesskind Dan S

Relationship: Director
Address: C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL
Signature: /s/ Marina Gofman Feler, attorney-in-fact
Signature date: 29 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NNOX transaction

Ordinary Shares

Purchase

Transaction value: $23,500
Shares: +25,000
Change %
Price: $0.9400
Shares after: 25,000
Date: 27 Jul 2026
Ownership: Direct

NNOX transaction

Ordinary Shares

Purchase

Transaction value: $23,000
Shares: +25,000
Change %: +100%
Price: $0.9200
Shares after: 50,000
Date: 27 Jul 2026
Ownership: Direct

NNOX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,792
Date: 27 Jul 2026
Ownership: Direct
Footnotes: F1, F2

NNOX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,544
Date: 27 Jul 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,505
Date: 27 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 12,505
Exercise price: $64.61
Footnotes: F1, F4

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50,000
Date: 27 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 50,000
Exercise price: $17.63
Footnotes: F1, F5

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,000
Date: 27 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,000
Exercise price: $11.52
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F2

The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer on December 10, 2024 and that vest and settle for underlying shares in twelve equal quarterly installments (each for 8.33% of the RSUs granted) such that by the three-year anniversary of the grant date (December 10, 2027) all underlying shares will be issued to the Reporting Person.

Footnote F3

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on December 10, 2025 and that vest and settle for underlying shares in twelve equal quarterly installments (each for 8.33% of the RSUs granted) such that by the three-year anniversary of the grant date (December 10, 2028) all underlying shares will be issued to the Reporting Person.

Footnote F4

The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report.

Footnote F5

The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and are fully vested and exercisable as of the date of this report.

Footnote F6

The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).

SEC remarks

Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .